CRH said Total revenues for Q3 2026 were $11.4 billion (Q3 2025 $11.1 billion), up 3% from the prior year. It said Net income was $1.2 billion ($1.5 billion a year earlier), and Adjusted EBITDA was in line with the prior year at $2.7 billion.

1. 01

   CRH said Total revenues for Q3 2026 were $11.4 billion (Q3 2025 $11.1 billion), up 3% from the prior year. It said Net income was $1.2 billion ($1.5 billion a year earlier), and Adjusted EBITDA was in line with the prior year at $2.7 billion.

2. 02

   The company said Loss on impairments for Q3 was $178 million (Q3 2025 $40 million), related to the Philippines reporting unit within International Solutions. It said the decline in Net income from the prior year was mainly due to Loss on impairments.

3. 03

   CRH said it completed the acquisition of Arcosa on October 23, 2026, with an enterprise value of about $8.5 billion, or $150.00 per share in cash. It said the deal was financed with proceeds from a $2.5 billion term loan facility, a $3.3 billion bridge facility and cash on hand.

4. 04

   CRH said its Board of Directors approved a new share buyback program of up to $6 billion, running to the end of 2030. It said it repurchased about 0.8 million Ordinary Shares for $0.1 billion in Q3 2026, bringing total repurchases to $0.7 billion through Q3.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.